RankingsPricing
  1. US-listed companies
  2. MUSTANG BIO, INC.
  3. Raw

MUSTANG BIO, INC.MBIO

Market cap
$4.77M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net loss-13-31-31-46-60-66-78-52-16
Issuance of Common Shares Equity Fee on Equity Offering--------0
Common Shares Issuable Annual Stock Dividend--------1
Research and development - licenses acquired---122000
Stock-based compensation expenses-2533321-0
Depreciation-01122321
Amortization of debt discount1--12-00-
Amortization of operating lease right-of-use assets-----0000
Loss on disposal of property and equipment---------0
Asset impairment--------4
Gain on sale of property and equipment-------1-
Loss on extinguishment of debt--------3-
Gain on lease modification--------00
Prepaid expenses and other assets---1001-1-1
Related Party--------0-
Non related party-------4-0
Other receivables---0-00-0--
Accounts payable and accrued expenses---03-050-3
Payable and accrued expenses - related party-0000-00002
Deferred income-----0---0
Lease liabilities----0-00010
Net cash used in operating activities--13-19-34-37-54-65-49-11
Purchase of research and development licenses-2112100-
Proceeds from the sale of property and equipment------06-
Purchase of fixed assets--722430-
Net cash from investing activities--29114-4-5-36-
Payment of debt-------30-
Proceeds from Issuance of Common Stock---3237---7
Offering costs for the issuance of common shares - Equity Offerings---22---1
Proceeds from issuance of common shares - At-the-Market Offering---236072703
Offering costs for the issuance of common shares - At-the-Market Offering---111000
Proceeds from Warrant Exercises--0-----4
Proceeds from Stock Plans----00000
Net cash provided by (used in) financing activities-50065787134-2611
Net change in cash, cash equivalents and restricted cash---453612-34-70-0
Cash paid for interest-0-12-31-
Stock Issued0410258411